Transient Neutropenia Induced by Intravenous Immune Globulin
- 23 January 1992
- journal article
- letter
- Published by Massachusetts Medical Society in New England Journal of Medicine
- Vol. 326 (4) , 270-271
- https://doi.org/10.1056/nejm199201233260413
Abstract
Intravenous immune globulin is used as an immunomodulatory agent in various autoimmune diseases.1 Adverse effects are uncommon but may include vasomotor symptoms such as chills, nausea, flushing, tightness of the chest, and wheezing.2 Hemolysis, thrombosis, alopecia, and liver-function disturbances have also been reported.3 4 5Keywords
This publication has 10 references indexed in Scilit:
- Clinical Uses of Intravenous ImmunoglobulinsAnnals of Internal Medicine, 1990
- ASTHMA - AUSTRALIA AND NEW ZEALANDAustralian and New Zealand Journal of Medicine, 1988
- ALOPECIA AFTER IMMUNOGLOBULIN INFUSIONThe Lancet, 1987
- Hemolysis following intravenous immune globulin therapyTransfusion, 1986
- THROMBOTIC EVENTS AFTER INTRAVENOUS IMMUNOGLOBULINThe Lancet, 1986
- Effect of intravenous immune globulin on natural killer cell activity: Possible association with autoimmune neutropenia and idiopathic thrombocytopeniaThe Journal of Pediatrics, 1986
- Intravenous Gammaglobulin Therapy in Idiopathic Thrombocytopenic PurpuraVox Sanguinis, 1985
- Reversal of neutropenia with intravenous gammaglobulin in autoimmune neutropenia of infancyBlood, 1983
- Identification by HLA Typing of Intrauterine-Derived Maternal T Cells in Four Patients with Severe Combined ImmunodeficiencyNew England Journal of Medicine, 1982
- SAFETY AND PATIENT ACCEPTABILITY OF INTRAVENOUS IMMUNE GLOBULIN IN 10% MALTOSEThe Lancet, 1980